Go Pro

Flputnam Investment Management Co. Buys Shares of 18,265 Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Flputnam Investment Management Co. purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 18,265 shares of the conglomerate's stock, valued at approximately $13,152,000.

A number of other hedge funds have also added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter worth $25,000. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth about $27,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

DHR stock opened at $202.51 on Monday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a market cap of $142.37 billion, a PE ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. The business has a 50 day moving average of $193.14 and a 200-day moving average of $192.91. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period last year, the company posted $0.77 earnings per share. Danaher's quarterly revenue was up 5.5% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Stifel Nicolaus dropped their price objective on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Royal Bank Of Canada lifted their target price on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Finally, Piper Sandler started coverage on Danaher in a research note on Thursday, June 11th. They set a "neutral" rating and a $200.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Check Out Our Latest Stock Report on DHR

About Danaher

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines